Integration of single-cell sequencing and experimental validation identified P2RY13/NF-κB as an immunological factor of patients with colorectal cancer
This study integrates single-cell and spatial transcriptomics with experimental validation to identify P2RY13 as a novel prognostic marker that suppresses colorectal cancer progression and M2 macrophage polarization by inhibiting the NF-κB pathway, while also characterizing distinct pro-inflammatory and pro-tumor macrophage subpopulations to inform precision immunotherapy strategies.